Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Avery

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
The British Journal of Ophthalmology|December 12, 2013
What is the evidence for systemic effects of intravitreal anti-VEGF agents, and should we be concerned?Robert L Avery
Ophthalmology|October 12, 2010
The plague and macular degenerationRobert L Avery
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|January 13, 2012
Bevacizumab (Avastin) for retinopathy of prematurity: wrong dose, wrong drug, or both?Robert L Avery
Retina (Philadelphia, Pa.)|March 2, 2006
Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatmentRobert L Avery
Ophthalmology|January 24, 2016
Re: Berg et al.: Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol (Ophthalmology 2015;122:146-52)Robert L Avery
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|August 18, 2009
Extrapolating anti-vascular endothelial growth factor therapy into pediatric ophthalmology: promise and concernRobert L Avery
Current Diabetes Reports|October 22, 2016
Vascular Endothelial Growth Factor Inhibitors for Diabetic RetinopathyDilsher S Dhoot, Robert L Avery
Expert Opinion on Biological Therapy|October 20, 2006
Ranibizumab: treatment in patients with neovascular age-related macular degenerationDante J Pieramici, Robert L Avery
JAMA Ophthalmology|October 30, 2015
Systemic Safety of Prolonged Monthly Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema: A Systematic Review and Meta-analysisRobert L Avery, Gabriel M Gordon
Retina (Philadelphia, Pa.)|October 11, 2019
Diagnostic and Therapeutic ChallengesLing Chen, Xinyue Bai, Robert L Avery
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
The British Journal of Ophthalmology|December 12, 2013
What is the evidence for systemic effects of intravitreal anti-VEGF agents, and should we be concerned?Robert L Avery
Ophthalmology|October 12, 2010
The plague and macular degenerationRobert L Avery
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|January 13, 2012
Bevacizumab (Avastin) for retinopathy of prematurity: wrong dose, wrong drug, or both?Robert L Avery
Retina (Philadelphia, Pa.)|March 2, 2006
Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatmentRobert L Avery
Ophthalmology|January 24, 2016
Re: Berg et al.: Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol (Ophthalmology 2015;122:146-52)Robert L Avery
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|August 18, 2009
Extrapolating anti-vascular endothelial growth factor therapy into pediatric ophthalmology: promise and concernRobert L Avery
Current Diabetes Reports|October 22, 2016
Vascular Endothelial Growth Factor Inhibitors for Diabetic RetinopathyDilsher S Dhoot, Robert L Avery
Expert Opinion on Biological Therapy|October 20, 2006
Ranibizumab: treatment in patients with neovascular age-related macular degenerationDante J Pieramici, Robert L Avery
JAMA Ophthalmology|October 30, 2015
Systemic Safety of Prolonged Monthly Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema: A Systematic Review and Meta-analysisRobert L Avery, Gabriel M Gordon
Retina (Philadelphia, Pa.)|October 11, 2019
Diagnostic and Therapeutic ChallengesLing Chen, Xinyue Bai, Robert L Avery
Pageof 6